Posted inCardiology Clinical Updates news Specialties
Empagliflozin’s Impact on Peripheral Microvascular Function in HFpEF: A Novel Vascular Insight
Empagliflozin alters peripheral microvascular responses in HFpEF patients, enhancing insulin-mediated vasodilation but reducing acetylcholine responsiveness, suggesting a targeted vascular mechanism distinct from general endothelial or smooth muscle effects.